Allspring Global Investments
NUVB icon

Allspring Global Investments’s Nuvation Bio NUVB Stock Holding History

Allspring Global Investments’s Portfolio NUVB Stock Details NUVB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-474
Closed -$853 – 2861
2023
Q2 		$853 Sell
474
-824
-63% -$1.4K ﹤0.01% 2664
2023
Q1 		$2.15K Buy
1,298
+1,039
+401% +$2.11K ﹤0.01% 2707
2022
Q4 		$497 Buy
+259
New +$524 ﹤0.01% 2896
2022
Q2 		– Sell
-79,208
Closed -$416K – 2848
2022
Q1 		$416K Buy
79,208
+24,706
+45% +$139K ﹤0.01% 2299
2021
Q4 		$463K Buy
+54,502
New +$501K ﹤0.01% 2327

Other funds holding NUVB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACM
Abrams Capital Management Boston, Massachusetts $4.64B AUM 1.52% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Allspring Global Investments's NUVB Position: Q3 2023 in Review

Allspring Global Investments sold out of Nuvation Bio (NUVB) in Q3 2023, closing a stake of 474 shares — an estimated $853 sold.

Allspring Global Investments first reported a position in NUVB in Q4 2021 and held it in 5 quarters. The position peaked at $463K in Q4 2021. 125 funds tracked by Wall St. Rank hold NUVB as of Q3 2023.

  • Allspring Global Investments reported no remaining Nuvation Bio position as of Q3 2023 after selling out during the quarter.
  • Allspring Global Investments sold 474 Nuvation Bio shares in Q3 2023, an estimated $853.
  • Allspring Global Investments first reported a position in Nuvation Bio in Q4 2021 and held it in 5 quarters.
  • Allspring Global Investments's Nuvation Bio position peaked at $463K in Q4 2021.
  • 125 funds tracked by Wall St. Rank held Nuvation Bio as of Q3 2023.

Based on Allspring Global Investments's 13F filing for Q3 2023, filed 27 Oct 2023.